Postoperative intravenous lidocaine infusion for pain management in pelvic bone tumor surgery patients: a randomized, double-blind, controlled trial
Key Points
To evaluate the efficacy of intravenous lidocaine infusion for pain management in patients undergoing pelvic bone tumor surgery.
Conducted a randomized, double-blind, controlled trial
Enrolled participants from a single center
Administered intravenous lidocaine infusion before and after surgery
Demonstrated reduced pain levels postoperatively in the lidocaine group
Compared to the control group, lidocaine significantly improved pain management outcomes
Abstract
This single-center, prospective RCT was registered with the Chinese Clinical Trial Registry (ChiCTR2100051207, 15/09/2021). The first research participant was enrolled in September 20, 2021.
Postoperative intravenous lidocaine infusion for pain management in pelvic bone tumor surgery patients: a randomized, double-blind, controlled trial | Synapse